Clinical Trials Directory

Trials / Unknown

UnknownNCT05220527

Effects of Knee Injections on Patients With Knee Osteoarthritis

Therapeutic Effects of Knee Intra-articular Injections on Patients With Knee Osteoarthritis: a Double-blind, Randomized, Placebo-controlled Clinical Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Taipei Medical University · Academic / Other
Sex
All
Age
40 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Using a double-blind, randomized, placebo-controlled design to compare the immediate, short-term, and intermediate-term additional therapeutic effects of ultrasound-guided corticosteroid injection and dextrose injection to hyaluronic acid injection on patients with knee osteoarthritis, under the basis of International Classification of Functioning, Disability and Health.

Detailed description

A total of 60 patients will be collected. The participants will be randomized into three groups, including the hyaluronic acid combined corticosteroid group, hyaluronic acid combined dextrose group, and hyaluronic acid combined normal saline group (placebo group). The functional performance and knee-related quality of life (Western Ontario and McMaster Universities Osteoarthritis index、Knee Injury and Osteoarthritis Outcome Score), pain (pressure threshold by pain pressure ergometer), and physical activity (10 meters normal and fast walk, up and downstairs, 5 repeated chair-rising time, timed up and go test) and image progression by high-resolution ultrasound will be evaluated before treatment, one week after injections, one month after injections, three months after injections, and six months after injections. Participants and evaluators will be both blinded to the group's allocation during the whole course of intervention.

Conditions

Interventions

TypeNameDescription
DRUGTriamcinolone plus hyruantriamcinolone plus hyruan injections, one time per week, for 3 weeks
DRUGvitagen plus hyruanvitagen plus hyruan injections, one time per week, for 3 weeks
DRUGnormal saline plus hyruannormal saline plus hyruan injections, one time per week, for 3 weeks

Timeline

Start date
2020-08-01
Primary completion
2022-07-31
Completion
2022-07-31
First posted
2022-02-02
Last updated
2022-02-02

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05220527. Inclusion in this directory is not an endorsement.